Characteristic | n (%) | |
Sex Male Female |
35 (55.8) 28 (44.4) | |
Age (years), mean ± SD | 63.38 | ±11.107 |
Comorbidities (n = 63) Hypertension Coronary artery disease Cerebrovascular disease Chronic obstructive pulmonary disease |
46 (73) 11 (17.5) 3 (4.8) 2 (3.2) | |
Body mass index, kg/m2 (n = 58) (WHO general population [16] ) <18.5 (Underweight) 18.5 - 24.9 (normal weight) >25.0 - 29.9 (pre-obesity) |
2 (3.2) 37 (58.7) 19 (30.2) | |
Medications Calcium carbonate (CaC03) Erythrocyte-stimulating agent Iron Dipeptidyl peptidase-4 inhibitor inhibitors Calcium channel blockers Angiotensin receptor blockers Antiplatelet Angiotensin-converting enzyme inhibitor Nitrates Insulin Alpha 2 agonists Statins Sevelamer carbonate |
57 (90.5) 54 (85.7) 53 (84.1) 37 (58.7) 34 (54.0) 32 (50.8) 21 (33.3) 20 (31.7) 16 (25.4) 12 (19.0) 9 (14.3) 6 (9.5) 3 (4.8) |